drugset / Trial / NCT05906056

Continuous Passive Motion Versus Heterotopic Ossification

NCT05906056

Recruiting 20 enrolled University of Ioannina
RandomizedParallel-groupSingle-blindPrevention

Summary

The investigators hypothesize that Heterotopic Ossification (HO) formation can be suppressed if the application of a Continuous Passive Motion (CPM) device can be performed for a substantial amount of time. The investigators will use the following study design: a pilot study with 10 ICU patients receiving CPM and 10 matched cases which will follow a conventional physiotherapy program at the time of the conduction of the study. The comparison between the treatment and referent groups of the outcomes will prove the prophylactic power of CPM against HO.

Timeline

Start
2023-05-12
Primary completion
2026-04-25
Completion
2027-03-25

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Zoledronic acid Other / unclassified Intravenous